Showing 1 - 5 results of 5 for search 'Klaus-Uwe Kirchgaessler', query time: 0.02s
Refine Results
-
1
-
2
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002) by Mark H. Gotfried, Carlos E. Girod, Danielle Antin-Ozerkis, Tracy Burgess, Indiana Strombom, John L. Stauffer, Klaus-Uwe Kirchgaessler, Maria L. Padilla
Published 2018-06-01
Article -
3
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema by Athol U. Wells, Joseph Jacob, Nicola Sverzellati, Gary Cross, Joseph Barnett, Angelo De Lauretis, Katerina Antoniou, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin
Published 2024-01-01
Article -
4
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease by Toby M. Maher, Courtney Schiffman, Michael Kreuter, Catharina C. Moor, Steven D. Nathan, Judit Axmann, Paula Belloni, Monica Bengus, Frank Gilberg, Klaus-Uwe Kirchgaessler, Marlies S. Wijsenbeek
Published 2022-11-01
Article -
5
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis by Maria Molina-Molina, Maria Molina-Molina, Michael Kreuter, Michael Kreuter, Vincent Cottin, Vincent Cottin, Tamera J. Corte, Tamera J. Corte, Frank Gilberg, Klaus-Uwe Kirchgaessler, Judit Axmann, Toby M. Maher, Toby M. Maher, Toby M. Maher
Published 2022-06-01
Article